Patient Safety First!

How to Effectively Reduce Human Papillomavirus (HPV) Cross-Contamination Risk in Ultrasound Examinations

Fertility Conference Webinar

How to Effectively Reduce Human Papillomavirus (HPV) Cross-Contamination Risk in Ultrasound

Speakers: Dr Craig Meyers, World Renowned Expert in HPV Research, Professor of Microbiology and Immunology, Penn State College of Medicines & Dr David Weber, Professor of Medicine, Pediatrics, Epidemiology Associate Chief Medical Officer, UNC Hospitals Medical Director, Hospital Epidemiology

Host: Glen Ewing, Director, Germitec UK    

Synopsis: Dr David Weber will provide a research overview on vaginal ultrasound probe contamination despite the use of probe covers and Low-Level Disinfection. Dr Craig Meyers will then give his expertise in HPV research. He was the first lab to develop a technique to grow natural High-Risk HPV that causes 90% of cervical cancer and other anogenital cancers. He will discuss how it has been applied in product research to ensure US probe reprocessing effectively kills the virus.

Q&A Discussion topics

What is the process for a manufacturer to have their medical device tested against HPV, and what is the time frame?

  • “Need to contact the company directly to find out if the medical device has been HPV tested. As not all tests get published.”
  • “We discuss with the company test protocols and controls when designing the HPV study. The test outcomes take about four weeks.”

Cervical cancer incidence – Key Stats.

  • About 351,720 new cervical cancer cases are diagnosed annually in Asia (estimations for 2020).
  • Cervical cancer ranks* as the 4th leading cause of female cancer in Asia.
  • Cervical cancer is the 3rd most common female cancer in women aged 15 to 44 years in Asia
Rate of cervical cancer cases attributable to HPV by country in Asia
HPV Cervical Cancer Ultrasound
Download HPV-Patient Safety First

Chronos®
is leading the way in High Level Disinfection (HLD)

Chronos® automated UV-C High Level Disinfection (HLD) system is proven to kill native human papillomavirus (HPV) both in vitro and in clinical use.2-3

Chronos HPV tested
Pr Meyers - UVC radiation as an effective disinfectant method to inactivate - Research Paper
Download Flyer HPV Research in Clinical Practice
Download Flyer HPV Research Drives Change in Clinical Practice

What Next!

Watch The Next Webinar

Click Here

First In-Use Study on Human Papillomavirus (HPV) Conducted in a Clinical Environment

Click Here

  1. Meyers J, Ryndock E, Conway MJ, Meyers C, Robison R. Susceptibility of high-risk human papillomavirus type 16 to clinical disinfectants. J Antimicrob Chemother. 2014;69(6):1546-50.
  2. Meyers C, Milici J, Robison R (2017) UVC radiation as an effective disinfectant method to inactivate human papillomaviruses. PLoS ONE 12 (10): e0187377.
  3. Maxime Pichon, Karine LebailCarval, Geneviève Billaud, Bruno Lina, Pascal Gaucherand and Yahia Mekki (2019) Decontamination of Intravaginal Probes Infected by Human Papillomavirus (HPV) Using UV-C Decontamination System. J. Clin. Med, 8, 1776; doi:10.3390/jcm8111776.
  4. Johnson. S. et al.(2013) Evaluation of a Hydrogen Peroxide-Based System for High-Level
    Disinfection of Vaginal Ultrasound Probes, Journal of Ultrasound Medicine, 321799-804,
  5. Meyers C, et al. (2020). The ability of two chlorine dioxide chemistries to inactivate human papillomavirus-contaminated endocavitary ultrasound probes and nasendoscopes. doi:10.1002/jmv.25666. Epub 2020 Feb 4. PMID: 31919857; PMCID: PMC7497195.
  6. C. Kyriacou, et al (2021) Time effectiveness and convenience of transvaginal ultrasound probe disinfection using ultraviolet vs chlorine dioxide multistep wipe system: prospective survey study. https://doi.org/10.1002/uog.24834
Scroll to Top